| Value | ₹823.6 Cr |
|---|
NSE filing, NSE: SSEGL. Summary written from the filing by ALFA Finder's alert engine.
Sathlokhar Synergys E&C Global Ltd: key numbers
- Share price
- ₹357.65
- Market cap
- ₹929.1 Cr
- Revenue (annual)
- ₹820.3 Cr
- Net profit (annual)
- ₹82.32 Cr
- P/E (TTM)
- 11.3×Sector 32.4×
- Promoter holding
- 58.27%+0.00% QoQ
- FII holding
- 0.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sathlokhar Synergys E&C Global Ltd
All →Sathlokhar Synergys E&C Global Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹297 Cr (+100% YoY), PAT ₹29 Cr (9.9% margin). H1 revenue ₹502 Cr, PAT ₹51 Cr. Backward integration into PEB manufacturing.
Sathlokhar Synergys E&C Global Results Update
Sathlokhar Synergys reported Q2 FY27 revenue of ₹297 crore and PAT of ₹29 crore, up 100% and 111% YoY. Order book stands at ₹1,139 crore.
- PEB manufacturing capacity
- 1200 MT/month
Sathlokhar Synergys E&C Global Other Announcement
Sathlokhar Synergys filed its Q2 FY27 Reg 32 statement confirming no deviation in utilization of preferential issue proceeds. The company utilized ₹737.70 Cr of ₹932.36 Cr received, with no variation from stated objects.
Sathlokhar Synergys E&C Global Q2 FY27 Results: Net Profit ₹29.2 Cr, Up 110.1% YoY
Sathlokhar Synergys E&C Global Ltd reported revenue from operations of ₹296.7 Cr (+99.9% YoY) and net profit of ₹29.2 Cr (+110.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹29.2 Cr · +110.1% YoY
Sathlokhar Synergys E&C Global Board Meeting Date
Sathlokhar Synergys E&C Global Limited has intimated a board meeting on 30-Oct-2026 to approve Q1 FY27 unaudited standalone financial results. The trading window is closed from 1-Oct-2026 to 16-Nov-2026.
Sathlokhar Synergys E&C Global Other Announcement
Sathlokhar Synergys E&C Global Limited has submitted the compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Other results update announcements
All →Narayana Hrudayalaya Results Update
Narayana Hrudayalaya reported Q2 FY27 consolidated revenue of Rs 28,440 Mn, up 73% YoY. PAT rose 16.6% to Rs 3,012 Mn, with the UK acquisition boosting revenue.
Corona Remedies Results Update
Corona Remedies released unaudited Q2 and H1 FY27 results highlights via press release. Revenue grew 22% year on year, with EBITDA and PAT also rising.
Acme Universal Safezone 9 Results Update
Acme Universal Safezone 9 reported H1FY27 revenue up 16.09% to ₹119.93 crore. EBITDA rose 54.62% and PAT turned to ₹7.02 crore profit.
Radiowalla Network Results Update
Radiowalla Network reported H1 FY27 revenue of ₹107.93 million, up 7% year-on-year. EBITDA rose to ₹8.16 million, with an 8% margin.
Artemis Medicare Services Results Update
Artemis Medicare reported Q2 FY27 consolidated revenue up 13.2% and PAT up 3.7% year-on-year. Adjusted EBITDA rose 22.7%, with the Raipur hospital launched in July 2026.
Advait Energy Transitions Results Update
Advait Energy reported Q2 FY27 consolidated revenue of ₹220.9 crore, up 40.8%, and PAT of ₹19.18 crore, up 88.5%. Its order book reached ₹1,574.8 crore.
- Order book
- ₹1,575 Cr